Features
Screener
Stocks Charts
Sign In Sign Up

Dr Reddy Financial Statements

NSE: DRREDDY | BSE: 500124 | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 5 years of history.

View Plans

Dr Reddy (DRREDDY) reported revenue of ₹337.00B in FY2026 with net income of ₹41.58B. Total assets stood at ₹581.23B. Net worth was ₹378.92B (₹37,892 Cr) and free cash flow was ₹33.43B.

Dr Reddy Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026
Item Chart 2025 2026
Revenue 326.44B 337.00B
Cost of Rev. -99.80B -122.39B
Gross Profit 226.64B 214.61B
SGA -141.17B -150.08B
Op. Income 68.43B 43.95B
PBT 76.58B 53.93B
Net Income 57.25B 41.58B
Dil. Shares 834.18M 833.33M
Diluted EPS 67.79 50.35

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Dr Reddy's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Dr Reddy Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026
Item Chart 2025 2026
Curr. assets 250.18B 301.79B
Non-curr. assets 244.09B 279.44B
Total assets 494.27B 581.23B
Curr. liabilities 130.34B 167.47B
Non-curr. liab. 24.65B 31.45B
Total liabilities 154.99B 198.93B
Total equity 339.27B 382.31B
Total liab. & eq. 494.27B 581.23B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Dr Reddy's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Dr Reddy Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026
Item Chart 2025 2026
Net Income 76.80B 53.93B
Operating CF 46.43B 56.74B
Capex -27.50B -23.31B
Investing CF -58.08B -65.49B
Dividend Paid -6.66B -6.66B
Financing CF 18.91B 8.29B
Cash (start) 7.11B 14.59B
Cash (end) 14.59B 15.37B
FCF 18.92B 33.43B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Dr Reddy's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026

Related Stocks